Your browser doesn't support javascript.
loading
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.
Gray, Jhanelle E; Chiappori, Alberto; Williams, Charlie C; Tanvetyanon, Tawee; Haura, Eric B; Creelan, Ben C; Kim, Jongphil; Boyle, Theresa A; Pinder-Schenck, Mary; Khalil, Farah; Altiok, Soner; Devane, Rebecca; Noyes, David; Mediavilla-Varela, Melanie; Smilee, Renee; Hopewell, Emily L; Kelley, Linda; Antonia, Scott J.
Afiliação
  • Gray JE; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, FOB1, Tampa, FL, 33612, USA. Jhanelle.gray@moffitt.org.
  • Chiappori A; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, FOB1, Tampa, FL, 33612, USA.
  • Williams CC; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, FOB1, Tampa, FL, 33612, USA.
  • Tanvetyanon T; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, FOB1, Tampa, FL, 33612, USA.
  • Haura EB; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, FOB1, Tampa, FL, 33612, USA.
  • Creelan BC; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, FOB1, Tampa, FL, 33612, USA.
  • Kim J; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Boyle TA; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Pinder-Schenck M; GlaxoSmithKline, Collegeville, PA, USA.
  • Khalil F; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Altiok S; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Devane R; Clinical Trials Office, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Noyes D; Clinical Science Lab (Antonia Lab), H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Mediavilla-Varela M; Clinical Science Lab (Antonia Lab), H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Smilee R; Cell Therapy Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Hopewell EL; Cell Therapy Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Kelley L; Cell Therapy Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Antonia SJ; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, FOB1, Tampa, FL, 33612, USA.
Cancer Immunol Immunother ; 67(12): 1853-1862, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30209589
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Fator Estimulador de Colônias de Granulócitos e Macrófagos / Carcinoma Pulmonar de Células não Pequenas / Vacinas Anticâncer / Ligante de CD40 / Quimiocina CCL21 / Imunoterapia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Fator Estimulador de Colônias de Granulócitos e Macrófagos / Carcinoma Pulmonar de Células não Pequenas / Vacinas Anticâncer / Ligante de CD40 / Quimiocina CCL21 / Imunoterapia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article